Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Myriad Genetics (MYGN) Shares Outstanding (Weighted Average): 2009-2025

Historic Shares Outstanding (Weighted Average) for Myriad Genetics (MYGN) over the last 16 years, with Sep 2025 value amounting to $93.0 million.

  • Myriad Genetics' Shares Outstanding (Weighted Average) rose 2.45% to $93.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $93.0 million, marking a year-over-year increase of 2.45%. This contributed to the annual value of $91.0 million for FY2024, which is 10.75% up from last year.
  • Myriad Genetics' Shares Outstanding (Weighted Average) amounted to $93.0 million in Q3 2025, which was up 0.94% from $92.2 million recorded in Q2 2025.
  • In the past 5 years, Myriad Genetics' Shares Outstanding (Weighted Average) registered a high of $93.0 million during Q3 2025, and its lowest value of $76.3 million during Q1 2021.
  • For the 3-year period, Myriad Genetics' Shares Outstanding (Weighted Average) averaged around $87.8 million, with its median value being $90.5 million (2024).
  • Data for Myriad Genetics' Shares Outstanding (Weighted Average) shows a peak YoY grew of 10.98% (in 2024) over the last 5 years.
  • Over the past 5 years, Myriad Genetics' Shares Outstanding (Weighted Average) (Quarterly) stood at $79.9 million in 2021, then increased by 1.48% to $81.0 million in 2022, then increased by 1.44% to $82.2 million in 2023, then rose by 10.75% to $91.0 million in 2024, then grew by 2.45% to $93.0 million in 2025.
  • Its Shares Outstanding (Weighted Average) stands at $93.0 million for Q3 2025, versus $92.2 million for Q2 2025 and $91.3 million for Q1 2025.